These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 6125174)

  • 1. Vasodilating properties of beta-adrenoceptor blockers with intrinsic sympathomimetic activity.
    Thulesius O; Gjöres JE; Berlin E
    Br J Clin Pharmacol; 1982; 13(Suppl 2):229S-230S. PubMed ID: 6125174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between beta adrenoceptor occupancy and receptor down-regulation induced by beta antagonists with intrinsic sympathomimetic activity.
    Lima JJ
    J Recept Signal Transduct Res; 1996; 16(5-6):357-72. PubMed ID: 8968966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharmacological studies of celiprolol: I. Beta-blocking effect, intrinsic sympathomimetic activity, vasodilating and hypotensive effects].
    Miura A; Kimura Y; Inoue K; Matsuzaki T; Ochi S; Hamada K; Hayashi S; Tamura M; Kano S; Kimura K
    Nihon Yakurigaku Zasshi; 1990 Apr; 95(4):191-200. PubMed ID: 1973398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Celiprolol does not protect against ventricular tachycardia or sudden death in the conscious canine: a comparison with pindolol in assessing the role of intrinsic sympathomimetic activity.
    Uprichard AC; Chi LG; Kitzen JM; Lynch JJ; Frye JW; Lucchesi BR
    J Pharmacol Exp Ther; 1989 Nov; 251(2):571-7. PubMed ID: 2572693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrinsic sympathomimetic activity of (-)-pindolol mediated through a (-)-propranolol-resistant site of the beta1-adrenoceptor in human atrium and recombinant receptors.
    Joseph SS; Lynham JA; Molenaar P; Grace AA; Colledge WH; Kaumann AJ
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Dec; 368(6):496-503. PubMed ID: 14608456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Intrinsic sympathomimetic action and its special features as demonstrated by the beta-1-receptor blocker celiprolol].
    Pittner H
    Wien Klin Wochenschr Suppl; 1985; 162():1-21. PubMed ID: 2861698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Celiprolol has no direct or indirect relaxing effects in isolated arteries and veins.
    O'Rourke ST; Vanhoutte PM
    J Cardiovasc Pharmacol; 1990 May; 15(5):831-5. PubMed ID: 1692945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of (+/-)-, (+)- and (-)-celiprolol and bromoacetylalprenololmentane at the beta-adrenoceptors of rat isolated cardiovascular preparations.
    Doggrell SA
    J Pharm Pharmacol; 1990 May; 42(5):319-24. PubMed ID: 1976778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relaxant and beta 2-adrenoceptor blocking activities of (+/- )-, (+)- and (-)-pindolol on the rat isolated aorta.
    Doggrell SA
    J Pharm Pharmacol; 1990 Jun; 42(6):444-6. PubMed ID: 1979630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological studies on the intrinsic sympathomimetic activity of the beta-adrenoceptor antagonist mepindolol.
    Beckmann R; Müller B; Schröder G; Stock G
    Arzneimittelforschung; 1986 May; 36(5):811-3. PubMed ID: 2873820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Desensitization pattern of cardiac beta-adrenoceptor subtypes by prolonged in vivo infusion of pindolol and celiprolol in rats.
    Nanoff C; Ströher M; Haschkowitz H; Schütz W; Pittner H
    Basic Res Cardiol; 1990; 85(1):88-95. PubMed ID: 1970235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential changes in lymphocyte beta 2-adrenoceptor density by beta-blocker administration: role of intrinsic sympathomimetic activity.
    Daul A; Wang XL; Borchard U; Bock KD; Brodde OE
    J Cardiovasc Pharmacol; 1986; 8 Suppl 4():S93-6. PubMed ID: 2427860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative analysis of beta-1 adrenoceptor agonist and antagonist potency and selectivity of cicloprolol, xamoterol and pindolol.
    Hicks PE; Cavero I; Manoury P; Lefevre-Borg F; Langer SZ
    J Pharmacol Exp Ther; 1987 Sep; 242(3):1025-34. PubMed ID: 2888869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of beta-adrenoceptor blocking properties of sotalol, oxprenolol, propranolol and pindolol on rabbit intestinal smooth muscle.
    Salimi M
    Pharmacology; 1975; 13(5):441-7. PubMed ID: 1802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of hypotensive mechanisms of pindolol, a beta-adrenoceptor blocking drugs in rats.
    Ozawa H; Matsubara T; Chen CS
    Jpn J Pharmacol; 1977 Apr; 27(2):295-302. PubMed ID: 18631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular mechanism of beta-adrenergic receptor blockers with intrinsic sympathomimetic activity.
    Jasper JR; Michel MC; Insel PA
    FASEB J; 1988 Oct; 2(13):2891-4. PubMed ID: 2901994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The beta 1- and beta 2-adrenoceptor stimulatory effects of alprenolol, oxprenolol and pindolol: a study in the isolated right atrium and uterus of the rat.
    Abrahamsson T
    Br J Pharmacol; 1986 Apr; 87(4):657-64. PubMed ID: 2871880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacology of celiprolol.
    Louis WJ; Drummer OH; Tung LH
    Cardiovasc Drugs Ther; 1991 Jan; 4 Suppl 6():1281-5. PubMed ID: 1672604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-Adrenoceptor studies. 4. Influence of albumin on in vitro beta-adrenoceptor blocking and antiarrhythmic properties of propranolol, pindolol, practolol and metoprolol.
    Zaagsma J; Meems L; Boorsma M
    Naunyn Schmiedebergs Arch Pharmacol; 1977 May; 298(1):29-36. PubMed ID: 18685
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of an antihypertensive agent, nipradilol, on isolated coronary artery of the dog.
    Sakanashi M; Takeo S; Ito H; Noguchi K; Miyamato Y; Higa T
    Pharmacology; 1984; 29(5):241-6. PubMed ID: 6149568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.